Tocilizumab in COVID-19: Factors Associated With Mortality Before and After Treatment

• Main Authors: Luis Sarabia De Ardanaz (Author), Jose M. Andreu-Ubero (Author), Miriam Navidad-Fuentes (Author), Miguel Ángel Ferrer-González (Author), Victor Ruíz del Valle (Author), Inmaculada Salcedo-Bellido (Author), Rocío Barrios-Rodríguez (Author), Rafael Cáliz-Cáliz (Author), Pilar Requena (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Tocilizumab (TCZ) has been administered in SARS-CoV-2 pneumonia but the factors associated with mortality before and after treatment remain unclear. Cox regression models were used to estimate the predictors of time to death in a cohort of hospitalized patients with COVID-19 receiving TCZ. In additi...